IOLVIP

IOLVIP

IOLVIP

Intraocular lens system to compensate for macular degeneration


The Intraocular Lens for Visually Impaired Patients (IOLVIP or IOL-VIP) is an intraocular lens system aiming to treat patients with poor central vision due to age related macular degeneration. The IOLVIP procedure involves the surgical implantation of a pair of lenses that magnify and divert the image using the principals of the Galilean telescope.[1] By arranging the lenses it is possible to direct the image to a different part of the eye than the fovea, which is the centre of the macula and is usually used for detailed vision. The magnified image is projected on to a part of the eye not normally used for detailed vision. Magnification and patient training are both necessary to allow useful vision from this part of the retina.

Diagram describing the IOLVIP procedure

It is a procedure to give symptomatic relief rather than treat disease and is best understood as an implanted miniature telescope.[2]

The procedure was pioneered in Italy and has since been taken to the UK and USA. It should not be used in anyone with active (that is changing) macular degeneration.[3] It can be used in both "burned out" wet macular degeneration and in dry or atrophic macular degeneration. A telescopic simulator can be used to assess whether the surgery might be helpful, and to establish the best rotation for the two lenses.[4]


References

  1. "Archived copy" (PDF). Archived from the original (PDF) on March 12, 2012. Retrieved August 23, 2010.{{cite web}}: CS1 maint: archived copy as title (link)
  2. "Archived copy" (PDF). Archived from the original (PDF) on March 12, 2012. Retrieved August 23, 2010.{{cite web}}: CS1 maint: archived copy as title (link)
  3. "Iol-Vip Faq". Archived from the original on August 5, 2010. Retrieved August 23, 2010.
  4. "Sapphire Eye Care". Sapphire Eye Care. Retrieved 2016-06-30.

Share this article:

This article uses material from the Wikipedia article IOLVIP, and is written by contributors. Text is available under a CC BY-SA 4.0 International License; additional terms may apply. Images, videos and audio are available under their respective licenses.